ENG(Endoglin Precursor) Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: E39315A67463EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of ENG(Endoglin Precursor) in Global, including the following market information:

Global ENG(Endoglin Precursor) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ENG(Endoglin Precursor) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ENG(Endoglin Precursor) include Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Bio-Rad, Abbexa Ltd, Boster Bio, Atlas Antibodies, Biobyt and Novus Biologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ENG(Endoglin Precursor) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ENG(Endoglin Precursor) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ENG(Endoglin Precursor) Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global ENG(Endoglin Precursor) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ENG(Endoglin Precursor) Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global ENG(Endoglin Precursor) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ENG(Endoglin Precursor) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ENG(Endoglin Precursor) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ENG(Endoglin Precursor) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Lifespan Biosciences
• Bio-Rad
• Abbexa Ltd
• Boster Bio
• Atlas Antibodies
• Biobyt
• Novus Biologicals
• Aviva Systems Biology
• ProSci
• BioLegend

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ENG(Endoglin Precursor) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ENG(Endoglin Precursor) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENG(ENDOGLIN PRECURSOR) OVERALL MARKET SIZE

2.1 Global ENG(Endoglin Precursor) Market Size: 2021 VS 2028
2.2 Global ENG(Endoglin Precursor) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ENG(Endoglin Precursor) Players in Global Market
3.2 Top Global ENG(Endoglin Precursor) Companies Ranked by Revenue
3.3 Global ENG(Endoglin Precursor) Revenue by Companies
3.4 Top 3 and Top 5 ENG(Endoglin Precursor) Companies in Global Market, by Revenue in 2021
3.5 Global Companies ENG(Endoglin Precursor) Product Type
3.6 Tier 1, Tier 2 and Tier 3 ENG(Endoglin Precursor) Players in Global Market
  3.6.1 List of Global Tier 1 ENG(Endoglin Precursor) Companies
  3.6.2 List of Global Tier 2 and Tier 3 ENG(Endoglin Precursor) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ENG(Endoglin Precursor) Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global ENG(Endoglin Precursor) Revenue & Forecasts
  4.2.1 By Type - Global ENG(Endoglin Precursor) Revenue, 2017-2022
  4.2.2 By Type - Global ENG(Endoglin Precursor) Revenue, 2023-2028
  4.2.3 By Type - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ENG(Endoglin Precursor) Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global ENG(Endoglin Precursor) Revenue & Forecasts
  5.2.1 By Application - Global ENG(Endoglin Precursor) Revenue, 2017-2022
  5.2.2 By Application - Global ENG(Endoglin Precursor) Revenue, 2023-2028
  5.2.3 By Application - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ENG(Endoglin Precursor) Market Size, 2021 & 2028
6.2 By Region - Global ENG(Endoglin Precursor) Revenue & Forecasts
  6.2.1 By Region - Global ENG(Endoglin Precursor) Revenue, 2017-2022
  6.2.2 By Region - Global ENG(Endoglin Precursor) Revenue, 2023-2028
  6.2.3 By Region - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ENG(Endoglin Precursor) Revenue, 2017-2028
  6.3.2 US ENG(Endoglin Precursor) Market Size, 2017-2028
  6.3.3 Canada ENG(Endoglin Precursor) Market Size, 2017-2028
  6.3.4 Mexico ENG(Endoglin Precursor) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ENG(Endoglin Precursor) Revenue, 2017-2028
  6.4.2 Germany ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.3 France ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.4 U.K. ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.5 Italy ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.6 Russia ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.7 Nordic Countries ENG(Endoglin Precursor) Market Size, 2017-2028
  6.4.8 Benelux ENG(Endoglin Precursor) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ENG(Endoglin Precursor) Revenue, 2017-2028
  6.5.2 China ENG(Endoglin Precursor) Market Size, 2017-2028
  6.5.3 Japan ENG(Endoglin Precursor) Market Size, 2017-2028
  6.5.4 South Korea ENG(Endoglin Precursor) Market Size, 2017-2028
  6.5.5 Southeast Asia ENG(Endoglin Precursor) Market Size, 2017-2028
  6.5.6 India ENG(Endoglin Precursor) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ENG(Endoglin Precursor) Revenue, 2017-2028
  6.6.2 Brazil ENG(Endoglin Precursor) Market Size, 2017-2028
  6.6.3 Argentina ENG(Endoglin Precursor) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ENG(Endoglin Precursor) Revenue, 2017-2028
  6.7.2 Turkey ENG(Endoglin Precursor) Market Size, 2017-2028
  6.7.3 Israel ENG(Endoglin Precursor) Market Size, 2017-2028
  6.7.4 Saudi Arabia ENG(Endoglin Precursor) Market Size, 2017-2028
  6.7.5 UAE ENG(Endoglin Precursor) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific ENG(Endoglin Precursor) Major Product Offerings
  7.1.4 Thermo Fisher Scientific ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems ENG(Endoglin Precursor) Major Product Offerings
  7.2.4 R&D Systems ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Lifespan Biosciences
  7.3.1 Lifespan Biosciences Corporate Summary
  7.3.2 Lifespan Biosciences Business Overview
  7.3.3 Lifespan Biosciences ENG(Endoglin Precursor) Major Product Offerings
  7.3.4 Lifespan Biosciences ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.3.5 Lifespan Biosciences Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad ENG(Endoglin Precursor) Major Product Offerings
  7.4.4 Bio-Rad ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd ENG(Endoglin Precursor) Major Product Offerings
  7.5.4 Abbexa Ltd ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio ENG(Endoglin Precursor) Major Product Offerings
  7.6.4 Boster Bio ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Atlas Antibodies
  7.7.1 Atlas Antibodies Corporate Summary
  7.7.2 Atlas Antibodies Business Overview
  7.7.3 Atlas Antibodies ENG(Endoglin Precursor) Major Product Offerings
  7.7.4 Atlas Antibodies ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.7.5 Atlas Antibodies Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt ENG(Endoglin Precursor) Major Product Offerings
  7.8.4 Biobyt ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Novus Biologicals
  7.9.1 Novus Biologicals Corporate Summary
  7.9.2 Novus Biologicals Business Overview
  7.9.3 Novus Biologicals ENG(Endoglin Precursor) Major Product Offerings
  7.9.4 Novus Biologicals ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.9.5 Novus Biologicals Key News
7.10 Aviva Systems Biology
  7.10.1 Aviva Systems Biology Corporate Summary
  7.10.2 Aviva Systems Biology Business Overview
  7.10.3 Aviva Systems Biology ENG(Endoglin Precursor) Major Product Offerings
  7.10.4 Aviva Systems Biology ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.10.5 Aviva Systems Biology Key News
7.11 ProSci
  7.11.1 ProSci Corporate Summary
  7.11.2 ProSci Business Overview
  7.11.3 ProSci ENG(Endoglin Precursor) Major Product Offerings
  7.11.4 ProSci ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.11.5 ProSci Key News
7.12 BioLegend
  7.12.1 BioLegend Corporate Summary
  7.12.2 BioLegend Business Overview
  7.12.3 BioLegend ENG(Endoglin Precursor) Major Product Offerings
  7.12.4 BioLegend ENG(Endoglin Precursor) Revenue in Global Market (2017-2022)
  7.12.5 BioLegend Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ENG(Endoglin Precursor) Market Opportunities & Trends in Global Market
Table 2. ENG(Endoglin Precursor) Market Drivers in Global Market
Table 3. ENG(Endoglin Precursor) Market Restraints in Global Market
Table 4. Key Players of ENG(Endoglin Precursor) in Global Market
Table 5. Top ENG(Endoglin Precursor) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ENG(Endoglin Precursor) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ENG(Endoglin Precursor) Revenue Share by Companies, 2017-2022
Table 8. Global Companies ENG(Endoglin Precursor) Product Type
Table 9. List of Global Tier 1 ENG(Endoglin Precursor) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ENG(Endoglin Precursor) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ENG(Endoglin Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ENG(Endoglin Precursor) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ENG(Endoglin Precursor) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ENG(Endoglin Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ENG(Endoglin Precursor) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ENG(Endoglin Precursor) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ENG(Endoglin Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ENG(Endoglin Precursor) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ENG(Endoglin Precursor) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ENG(Endoglin Precursor) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ENG(Endoglin Precursor) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ENG(Endoglin Precursor) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ENG(Endoglin Precursor) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ENG(Endoglin Precursor) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific ENG(Endoglin Precursor) Product Offerings
Table 32. Thermo Fisher Scientific ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems ENG(Endoglin Precursor) Product Offerings
Table 35. R&D Systems ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 36. Lifespan Biosciences Corporate Summary
Table 37. Lifespan Biosciences ENG(Endoglin Precursor) Product Offerings
Table 38. Lifespan Biosciences ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad ENG(Endoglin Precursor) Product Offerings
Table 41. Bio-Rad ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd ENG(Endoglin Precursor) Product Offerings
Table 44. Abbexa Ltd ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio ENG(Endoglin Precursor) Product Offerings
Table 47. Boster Bio ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 48. Atlas Antibodies Corporate Summary
Table 49. Atlas Antibodies ENG(Endoglin Precursor) Product Offerings
Table 50. Atlas Antibodies ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt ENG(Endoglin Precursor) Product Offerings
Table 53. Biobyt ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 54. Novus Biologicals Corporate Summary
Table 55. Novus Biologicals ENG(Endoglin Precursor) Product Offerings
Table 56. Novus Biologicals ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 57. Aviva Systems Biology Corporate Summary
Table 58. Aviva Systems Biology ENG(Endoglin Precursor) Product Offerings
Table 59. Aviva Systems Biology ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 60. ProSci Corporate Summary
Table 61. ProSci ENG(Endoglin Precursor) Product Offerings
Table 62. ProSci ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)
Table 63. BioLegend Corporate Summary
Table 64. BioLegend ENG(Endoglin Precursor) Product Offerings
Table 65. BioLegend ENG(Endoglin Precursor) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ENG(Endoglin Precursor) Segment by Type in 2021
Figure 2. ENG(Endoglin Precursor) Segment by Application in 2021
Figure 3. Global ENG(Endoglin Precursor) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global ENG(Endoglin Precursor) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ENG(Endoglin Precursor) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ENG(Endoglin Precursor) Revenue in 2021
Figure 8. By Type - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 9. By Application - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 10. By Region - Global ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 11. By Country - North America ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 12. US ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 16. Germany ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 17. France ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 24. China ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 28. India ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 30. Brazil ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ENG(Endoglin Precursor) Revenue Market Share, 2017-2028
Figure 33. Turkey ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ENG(Endoglin Precursor) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lifespan Biosciences ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Atlas Antibodies ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novus Biologicals ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aviva Systems Biology ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ProSci ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioLegend ENG(Endoglin Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)